Newer drugs in the treatment of chronic bronchitis.
D000111:Acetylcysteine / Q000627:therapeutic use; D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000996:Antitussive Agents / Q000627:therapeutic use; D001991:Bronchitis / Q000188:drug therapy*; D002908:Chronic Disease; D005100:Expectorants / Q000627:therapeutic use*; D005990:Glycerol / Q000627:therapeutic use; D006139:Guaiacol / Q000627:therapeutic use; D006801:Humans; D008690:Methacycline / Q000627:therapeutic use; D010447:Peptide Hydrolases / Q000627:therapeutic use; D011437:Propylamines / Q000627:therapeutic use; D013412:Sulfadimethoxine / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use*; D013806:Theophylline / Q000627:therapeutic use; D013843:Thiazines / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000996:Antitussive Agents; D005100:Expectorants; D011437:Propylamines; D013449:Sulfonamides; D013843:Thiazines; D013412:Sulfadimethoxine; D006139:Guaiacol; D000667:Ampicillin; D013806:Theophylline; D010447:Peptide Hydrolases; D008690:Methacycline; D005990:Glycerol; D000111:Acetylcysteine